Reduced PATL2 Impairs the Proliferation of Ovarian Granulosa Cells by Decreasing ADM2 Expression in Patients with

Jun Tan1,2, Pei-Pei Liu3,4, Li-Yun Cao3,4

  • 1Reproductive Medicine Center, Jiangxi Maternal and Child Health Hospital, No. 318, Bayi Avenue, Donghu District, Nanchang, Jiangxi Province, China. tanjun561127@163.com.

Insights

Polycystic ovary syndrome (PCOS) impairs ovarian granulosa cell (GC) proliferation due to reduced PATL2, which stabilizes adrenomedullin 2 (ADM2). This leads to aberrant follicular development and infertility in PCOS patients.

Area of Science:

  • Reproductive biology
  • Cellular and molecular endocrinology

Background:

  • Polycystic ovary syndrome (PCOS) is linked to aberrant follicular development and infertility.
  • The regulatory mechanisms underlying abnormal follicular development in PCOS remain poorly understood.

Purpose of the Study:

  • To investigate the roles of PATL2 and adrenomedullin 2 (ADM2) in the proliferation of ovarian granulosa cells (GCs) from PCOS patients.
  • To elucidate the mechanism by which PATL2 influences GC proliferation and ADM2 expression.

Main Methods:

  • Collected human ovarian granulosa cells (GCs) from PCOS patients undergoing in vitro fertilization (IVF).
  • Utilized siRNA to knock down PATL2 expression in KGN cells (a GC line).
  • Constructed and transfected a PATL2 mutant plasmid into KGN cells.
  • Performed experiments on a rat PCOS model.

Main Results:

  • GCs from PCOS patients exhibited significantly reduced proliferation ability.
  • PATL2 and ADM2 expression were decreased in GCs from PCOS patients.
  • Knocking down PATL2 in KGN cells repressed GC growth and weakened ADM2 expression.
  • A PATL2 mutant lacking the "PAT" structure attenuated ADM2 expression and impaired GC proliferation.

Conclusions:

  • PATL2 promotes ovarian GC proliferation by stabilizing ADM2 expression via its "PAT" structure, supporting follicular development.
  • Reduced PATL2 in PCOS ovaries leads to decreased ADM2 expression, impaired GC proliferation, and aberrant follicle formation.